Summary
Circulating tumor DNA (ctDNA) is a blood test that can be used to detect and monitor thoracic malignancies. It is being used to detect mutations, monitor for recurrence after surgery and other treatments, and can even be used in conjunction with screening to help identify malignancy. As the field continues to advance, it is crucial for thoracic surgeons, trainees, and healthcare providers to stay informed about the latest developments in ctDNA testing and its applications for thoracic patients.
Sponsored by AstraZeneca
Moderators
Lana Y. Schumacher, MD
Tufts Medical Center
Boston, MA
Boris Sepesi, MD
HealthONE Physician Group
Aurora, CO
Presenters
Vincent Lam, MD
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD
Matthew Strickland, MD
Massachusetts General Hospital
Boston, MA